SAGE Therapeutics Inc Sage FutureCast: An R&D and Portfolio Review Transcript
Good morning, everyone, and thanks for joining the Second Annual Sage FutureCast call. I'm Jeff Boyle, Head of Investor Relations at Sage. Before we begin, I encourage everyone to go to the investor and media section of our website at sagerx.com, where you can find the press release related to today's call as well as slides that we will discuss.
I'd like to point out that we will be making forward-looking statements, which are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. Please consult the risk factors discussed in our SEC filings for additional details.
We will begin the call with prepared remarks by Dr. Jim Doherty, our Chief Research Officer; Dr. Rob Lasser, Vice President, Late Stage Development; Dr. Helen Colquhoun, Vice President, Early Development; Dr. Mike Quirk, Vice President, Pharmacology; Dr. Aaron Koenig, Medical Director, Early Development; Dr. Steve Kanes, our Chief Medical Officer; and then finally, Dr.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
